ResMed Inc.
RMD | NYSE
$224.75
+$1.14 (+0.51%)
Sep 22, 2026, 1:50 PM ET · Market open
TTM Period Ending | Q4 2026 Jun 29, 2026 | Q3 2026 Mar 30, 2026 | Q2 2026 Dec 30, 2025 | Q1 2026 Sep 29, 2025 | Q4 2025 Jun 29, 2025 | Q3 2025 Mar 30, 2025 | Q2 2025 Dec 30, 2024 | Q1 2025 Sep 29, 2024 | Q4 2024 Jun 29, 2024 | Q3 2024 Mar 30, 2024 | Q2 2024 Dec 30, 2023 | Q1 2024 Sep 29, 2023 | Q4 2023 Jun 29, 2023 | Q3 2023 Mar 30, 2023 | Q2 2023 Dec 30, 2022 | Q1 2023 Sep 29, 2022 | Q4 2022 Jun 29, 2022 | Q3 2022 Mar 30, 2022 | Q2 2022 Dec 30, 2021 | Q1 2022 Sep 29, 2021 | Q4 2021 Jun 29, 2021 | Q3 2021 Mar 30, 2021 | Q2 2021 Dec 30, 2020 | Q1 2021 Sep 29, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 5.65B | 5.54B | 5.4B | 5.26B | 5.15B | 5.02B | 4.93B | 4.81B | 4.69B | 4.58B | 4.5B | 4.38B | 4.22B | 4.02B | 3.76B | 3.62B | 3.58B | 3.54B | 3.44B | 3.35B | 3.2B | 3.09B | 3.09B | 3.03B |
Cost of Revenue | 2.2B | 2.12B | 2.11B | 2.1B | 2.09B | 2.08B | 2.07B | 2.04B | 2.03B | 2.02B | 2B | 1.96B | 1.87B | 1.75B | 1.63B | 1.57B | 1.55B | 1.55B | 1.5B | 1.44B | 1.36B | 1.29B | 1.29B | 1.26B |
Gross Profit | 3.46B | 3.42B | 3.29B | 3.16B | 3.05B | 2.94B | 2.85B | 2.77B | 2.66B | 2.57B | 2.5B | 2.41B | 2.36B | 2.26B | 2.13B | 2.06B | 2.02B | 1.99B | 1.95B | 1.91B | 1.84B | 1.8B | 1.8B | 1.76B |
Operating Income | 1.89B | 1.9B | 1.82B | 1.74B | 1.69B | 1.61B | 1.56B | 1.42B | 1.32B | 1.21B | 1.14B | 1.15B | 1.13B | 1.11B | 1.05B | 1.01B | 1B | 986.53M | 975.69M | 948.69M | 903.68M | 885.29M | 879.36M | 855.45M |
Interest Income | 20.89M | 5.76M | 6.55M | 6.55M | 6.55M | 4.42M | 6.98M | 6.98M | 6.98M | 3.35M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 59K | 114K | 246K | 363K | 559K | 620K | 690K |
Pretax Income | 1.92B | 1.9B | 1.82B | 1.74B | 1.68B | 1.58B | 1.53B | 1.38B | 1.26B | 1.18B | 1.1B | 1.11B | 1.1B | 1.06B | 999.89M | 963.49M | 960.48M | 961.6M | 953.29M | 926.6M | 883.66M | 856.55M | 830.2M | 798.36M |
Net Income | 1.52B | 1.52B | 1.49B | 1.44B | 1.4B | 1.31B | 1.25B | 1.11B | 1.02B | 958.38M | 890.39M | 906.5M | 897.56M | 862.95M | 809.47M | 786.3M | 779.44M | 779.47M | 521.98M | 499.74M | 474.5M | 457.24M | 698.86M | 679.9M |
Selling & General & Admin | 817.39M | 1.08B | 1.05B | 1.01B | 991.02M | 968.08M | 952.7M | 933.24M | 917.14M | 915.64M | 914.17M | 903.69M | 874.75M | 828.95M | 782.9M | 756.59M | 739.37M | 725.97M | 704.01M | 688.12M | 670.39M | 654.29M | 666.29M | 668.24M |
Research & Development | 378.29M | 359M | 348.68M | 339.08M | 331.28M | 325.7M | 318.83M | 311.34M | 307.53M | 304.81M | 304.17M | 300.16M | 287.64M | 273.82M | 264.18M | 256.81M | 253.58M | 249.13M | 238.27M | 230.7M | 225.28M | 217.93M | 213.44M | 208.45M |
Other Expenses | 369.35M | 76.53M | 70.32M | 63.67M | 47.3M | 33.34M | 22.45M | 109.68M | 110.75M | 134.04M | 146.23M | 65.93M | 61.4M | 46.02M | 41.56M | 31.32M | 31.08M | 30.88M | 30.59M | 39.22M | 39.75M | 40.27M | 41.1M | 33.29M |
Operating Expenses | 1.57B | 1.52B | 1.47B | 1.41B | 1.37B | 1.33B | 1.29B | 1.35B | 1.34B | 1.35B | 1.36B | 1.27B | 1.22B | 1.15B | 1.09B | 1.04B | 1.02B | 1.01B | 972.87M | 958.03M | 935.42M | 912.49M | 920.82M | 909.97M |
Interest Expense | 29.03M | 29.03M | 19.93M | 16.76M | 13.47M | 23.02M | 34.22M | 43.23M | 52.69M | 58.08M | 58.67M | 55.2M | 47.38M | 37.98M | 28.48M | 24.09M | 22.31M | 22.12M | 22.53M | 22.51M | 23.99M | 27.84M | 31.93M | 36.23M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 3.76B | 3.64B | 3.57B | 3.51B | 3.46B | 3.41B | 3.37B | 3.39B | 3.37B | 3.37B | 3.36B | 3.23B | 3.09B | 2.9B | 2.72B | 2.61B | 2.58B | 2.55B | 2.47B | 2.4B | 2.29B | 2.21B | 2.21B | 2.17B |
Income Tax Expense | 396.12M | 383.74M | 332.81M | 302.96M | 276.84M | 263.99M | 286.27M | 263.22M | 243.85M | 225.49M | 207.44M | 205.56M | 204.11M | 200M | 190.43M | 177.19M | 181.05M | 182.13M | 431.31M | 426.85M | 409.16M | 399.31M | 131.34M | 118.46M |
Shares Outstanding (Basic) | 144.71M | 146.47M | 146.47M | 146.47M | 146.47M | 146.72M | 146.86M | 146.86M | 146.92M | 146.96M | 147.13M | 147.08M | 147.02M | 146.91M | 146.7M | 146.43M | 146.36M | 146.24M | 145.99M | 145.68M | 145.6M | 145.34M | 145.25M | 144.9M |
Shares Outstanding (Diluted) | 144.98M | 147.04M | 147.04M | 147.04M | 147.04M | 147.22M | 147.6M | 147.6M | 147.53M | 147.45M | 147.55M | 147.49M | 147.55M | 147.4M | 147.41M | 147.13M | 147M | 146.96M | 147.04M | 146.86M | 146.54M | 145.51M | 146.42M | 146.1M |
EPS (Basic) | 10.44 | 10.38 | 10.15 | 9.81 | 9.55 | 8.95 | 8.50 | 7.57 | 6.94 | 6.51 | 6.05 | 6.16 | 6.11 | 5.88 | 5.52 | 5.37 | 5.33 | 5.34 | 3.58 | 3.44 | 3.27 | 3.16 | 4.83 | 4.70 |
EPS (Diluted) | 10.40 | 10.34 | 10.11 | 9.77 | 9.51 | 8.91 | 8.47 | 7.55 | 6.93 | 6.51 | 6.05 | 6.16 | 6.10 | 5.87 | 5.51 | 5.35 | 5.31 | 5.31 | 3.55 | 3.41 | 3.24 | 3.13 | 4.79 | 4.66 |
EBITDA | 2.15B | 2.19B | 2.07B | 1.98B | 1.92B | 1.75B | 1.73B | 1.63B | 1.52B | 1.5B | 1.42B | 1.37B | 1.35B | 1.29B | 1.22B | 1.18B | 1.18B | 1.18B | 1.17B | 1.15B | 1.11B | 1.08B | 1.08B | 1.03B |
EBIT | 1.95B | 1.93B | 1.84B | 1.75B | 1.69B | 1.54B | 1.51B | 1.43B | 1.32B | 1.3B | 1.22B | 1.17B | 1.15B | 1.11B | 1.03B | 987.57M | 982.79M | 983.72M | 975.36M | 962.52M | 915.27M | 892M | 886.08M | 844.66M |
Depreciation & Amortization | 197.86M | 253.35M | 236.23M | 229.8M | 235.81M | 216.28M | 219.01M | 200.96M | 200.69M | 201.14M | 199.28M | 206.97M | 197.56M | 187.37M | 186.19M | 190.26M | 193.84M | 194.51M | 190.79M | 189.25M | 191.52M | 191.35M | 189.93M | 187.34M |
Add to Watchlist
Select watchlists to add or remove RMD